Rosenbloom David S.
SEC CIK 1924321 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BAX | Baxter International | SVP, GC | 138.2K | — | — | 15 | 2022-06-01 | 2026-03-06 |
Most active insiders at BAX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Teaff James | Pres, CCS | — | — |
| 2 | Foster Julie | Pres, Front Line Care | — | — |
| 3 | Soriano Maria Cecilia | Group Pres, ITT, Pharma | — | — |
| 4 | Carlisle Cynthia | EVP, CHRO | — | — |
| 5 | Ampofo William A. II | Dir | — | — |
| 6 | Rasul Reazur | EVP, Group Pres, Healthcare | — | — |
| 7 | Hider Andrew P. | Pres, CEO, Dir | — | — |
| 8 | Rosenbloom David S. | EVP, GC | — | — |
| 9 | Wilkes David S. | Dir | — | — |
| 10 | Wallace Steven P. | Pres, Adv. Surgery | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-10 | 2026-03-06 | BAX | Baxter International | Rosenbloom David S. | EVP, GC | F - Tax | $17.69 | -6,620 | 138.2K | -5% | -$117.1K | |
| D | 2026-03-03 | 2026-02-27 | BAX | Baxter International | Rosenbloom David S. | EVP, GC | A - Grant | $0.00 | +26.7K | 146.2K | +22% | $0 |
| D | 2026-03-03 | 2026-03-02 | BAX | Baxter International | Rosenbloom David S. | EVP, GC | F - Tax | $19.69 | -1,336 | 144.8K | -0.9% | -$26.3K |
| 2026-02-11 | 2026-02-09 | BAX | Baxter International | Rosenbloom David S. | EVP, GC | F - Tax | $21.73 | -5,225 | 119.5K | -4% | -$113.5K | |
| 2026-02-11 | 2026-02-09 | BAX | Baxter International | Rosenbloom David S. | EVP, GC | A - Grant | $0.00 | +17.1K | 124.7K | +16% | $0 | |
| 2025-06-04 | 2025-06-02 | BAX | Baxter International | Rosenbloom David S. | EVP, GC | F - Tax | $29.55 | -16.5K | 106.3K | -13% | -$489.0K | |
| D | 2025-03-10 | 2025-03-06 | BAX | Baxter International | Rosenbloom David S. | EVP, GC | A - Grant | $0.00 | +17.7K | 122.4K | +17% | $0 |
| D | 2025-03-10 | 2025-03-06 | BAX | Baxter International | Rosenbloom David S. | EVP, GC | F - Tax | $35.44 | -4,922 | 104.8K | -4% | -$174.4K |
| 2025-03-05 | 2025-03-03 | BAX | Baxter International | Rosenbloom David S. | EVP, GC | F - Tax | $34.86 | -1,312 | 109.7K | -1% | -$45.7K | |
| 2024-06-05 | 2024-06-03 | BAX | Baxter International | Rosenbloom David S. | EVP, GC | F - Tax | $34.08 | -784 | 108.6K | -0.7% | -$26.7K | |
| 2024-03-08 | 2024-03-06 | BAX | Baxter International | Rosenbloom David S. | EVP, GC | A - Grant | $0.00 | +53.6K | 109.0K | +97% | $0 | |
| 2024-03-05 | 2024-03-01 | BAX | Baxter International | Rosenbloom David S. | EVP, GC | F - Tax | $41.01 | -1,416 | 55.4K | -2% | -$58.1K | |
| 2023-06-05 | 2023-06-01 | BAX | Baxter International | Rosenbloom David S. | SVP, GC | F - Tax | $41.23 | -762 | 55.6K | -1% | -$31.4K | |
| D | 2023-03-03 | 2023-03-01 | BAX | Baxter International | Rosenbloom David S. | SVP, GC | A - Grant | $0.00 | +13.9K | 56.1K | +33% | $0 |
| DM | 2022-06-03 | 2022-06-01 | BAX | Baxter International | Rosenbloom David S. | SVP, GC | A - Grant | $0.00 | +41.6K | 33.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations